Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE: 002932)
Health Care · Health Care Equipment & Supplies · CN
CN¥15.32
-0.07% today · -19.2% 1Y
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE: 002932) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $480.43M and employs 599 people.
Over the last twelve months the share price has lost 19.2%, trading between 13.67 and 20.87.
Tweenvest scores Wuhan Easy Diagnosis Biomedicine Co.,Ltd. across four factors: quality 65/100, value 53/100, growth 0/100. Its strongest factor is quality.
002932 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $480.43M
- Revenue (TTM)
- $39.34M
- P/E
- —
- EPS
- -0.21
- Dividend yield
- —
- Beta (5Y)
- 0.35
- 52-week high
- CN¥20.87
- 52-week low
- CN¥13.67
- Avg volume (3M)
- —
- Shares outstanding
- 210.05M
- Employees
- 599
- Next earnings
- —
About Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. specializes in the research, development, manufacturing, and global distribution of in vitro diagnostic (IVD) reagents and related equipment. Their extensive product line features molecular diagnostics, including genetic tests for drug metabolism and pathogen nucleic acid detection kits, alongside immunodiagnostic and blood gas analysis solutions. Beyond diagnostics, the company delivers comprehensive information solutions for emergency and critical illness, which encompass specialized software, supporting hardware, and expert certification consulting. They also provide third-party medical testing services. These offerings are applied across a broad spectrum of medical fields, addressing conditions such as cardiovascular, kidney, infectious, diabetes, endocrine, and metabolic diseases, as well as obstetrics and gynecology. Furthermore, their products support prenatal and postnatal care, general health check-ups, and specific analyses for thyroid function, hormones, blood gases, coagulation, drug metabolism, and pathogen identification. Established in 2008, the company is headquartered in Wuhan, China.
- ISIN
- CNE1000033Q7
- Founded
- 2008
- Listed since
- Jul 10, 2018
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Well Lead Medical Co., Ltd.SHSE: 603309 | $490.66M | CN¥11.26 | +0.72% |
| Shanghai ZJ Bio-Tech Co., LtdSHSE: 688317 | $489.85M | CN¥19.19 | -1.59% |
| Sight Sciences, Inc.NasdaqGS: SGHT | $489.73M | $8.81 | -0.96% |
| AngioDynamics, Inc.NasdaqGS: ANGO | $484.47M | $11.37 | -1.30% |
| medmix AGSWX: MEDX | $478.69M | CHF9.74 | -0.31% |
| Beijing Succeeder Technology Inc.SHSE: 688338 | $476.38M | CN¥30.69 | -3.34% |
| CareRay Digital Medical Technology Co., Ltd.SHSE: 688607 | $474.92M | CN¥36.40 | +2.39% |
| Senseonics Holdings, Inc.NasdaqGS: SENS | $474.81M | $9.12 | +1.56% |
Figures last refreshed Oct 11, 2026.